{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:08:29Z","timestamp":1778728109060,"version":"3.51.4"},"reference-count":49,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CPT Pharmacom &amp;amp; Syst Pharma"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Anti\u2010thymocyte globulin (ATG) is a polyclonal antibody used to prevent graft\u2010versus\u2010host disease in allogeneic hematopoietic stem cell transplantation. While recent studies have worked towards understanding the pharmacokinetic\u2013pharmacodynamic relationship via population pharmacokinetic modeling, dosing remains weight\u2010based and largely empirical in clinical practice. In this study, conventional and novel ATG dosing regimens were evaluated using Monte Carlo simulation and an in silico population of 10,000 representative adult patients. Individualized ATG dosing was examined using empirical Bayesian estimation and an optimisation function. Post\u2010transplant exposure was calculated, and the probability of target attainment was determined for each regimen. No conventional ATG dosing regimen was able to dose &gt;\u200925% of patients within the defined therapeutic target range of 60\u201395\u2009AU\u00b7day\/mL, with regimens utilizing total ATG doses of 4\u20135\u2009mg\/kg having the highest target attainment. Dose optimisation approaches were only able to improve on target attainment over baseline by up to 7%. In all cases, empirical Bayesian estimation of individual pharmacokinetic parameters was poor, with shrinkage &gt;\u200930% noted on three of the five parameters. These findings suggest that improving target attainment of ATG by means of model\u2010informed precision dosing is unlikely to be of clinical benefit in hematopoietic stem cell transplant recipients. Further research into factors affecting the pharmacokinetic parameters of ATG is required to allow for dose individualisation and treatment optimisation.<\/jats:p>","DOI":"10.1002\/psp4.70176","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:31:48Z","timestamp":1777606308000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Current and Novel Dosing Strategies for Anti\u2010Thymocyte Globulin in Adult Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1002","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-7628","authenticated-orcid":false,"given":"Elias","family":"Biris","sequence":"first","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"},{"name":"Pharmacy Department, Royal Adelaide Hospital  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5647-4673","authenticated-orcid":false,"given":"Phillip R.","family":"Selby","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"},{"name":"Pharmacy Department, Royal Adelaide Hospital  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-6256","authenticated-orcid":false,"given":"Tahlia R.","family":"Meola","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-7287","authenticated-orcid":false,"given":"Stephanie E.","family":"Reuter","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.10.2942"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70225-6"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506002"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00462-3"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.8177"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024725"},{"key":"e_1_2_11_8_1","article-title":"Polyclonal Anti\u2010Thymocyte Globulins for the Prophylaxis of Graft\u2010Versus\u2010Host Disease After Allogeneic Stem Cell or Bone Marrow Transplantation in Adults","volume":"6","author":"Chakupurakal G.","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02225-7"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284476"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.107"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.148510"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30256-X"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01889-y"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-3274(01)00048-X"},{"key":"e_1_2_11_16_1","first-page":"29","article-title":"The Pharmacokinetics of Anti\u2010Thymocyte Globulin (ATG) Following Intravenous Infusion in Man","volume":"45","author":"Bunn D.","year":"1996","journal-title":"Clinical Nephrology"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03342-8"},{"key":"e_1_2_11_18_1","first-page":"4349","article-title":"Pharmacokinetics and Pharmacodynamics of Two Antithymocyte Globulins in Treatment of Pediatric Aplastic Anemia","volume":"8","author":"Xie X.","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00127-7"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705911"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0505-5"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.027"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12224"},{"key":"e_1_2_11_24_1","first-page":"931","article-title":"Rabbit\u2010Immunoglobulin G Levels in Patients Receiving Thymoglobulin as Part of Conditioning Before Unrelated Donor Stem Cell Transplantation","volume":"90","author":"Remberger M.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.04.013"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.02.027"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.065"},{"key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"332.e331","DOI":"10.1016\/j.jtct.2022.03.018","article-title":"Optimal Active Anti\u2010Thymocyte Globulin Exposure Associated With Minimum Risk of Virus Reactivation and Comparable Acute Graft\u2010Versus\u2010Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation","volume":"28","author":"Wang H.","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0214-6"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30029-7"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27195"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030247"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005584"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12467"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01252-4"},{"key":"e_1_2_11_36_1","unstructured":"eviQ BMT Reference Committee \u201cAntithymocyte Globulin for Graft Versus Host Disease (Gvhd) Prophylaxis in Blood and Marrow Transplant (Bmt) \u201d(2021) [cited 2024] https:\/\/www.eviq.org.au\/clinical\u2010resources\/side\u2010effect\u2010and\u2010toxicity\u2010management\/haematological\/1027\u2010antithymocyte\u2010globulin\u2010for\u2010gvhd\u2010prophylaxis."},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1805114"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/11535960-000000000-00000"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.08.029"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00375-6"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00045-9"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.02.026"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.02.015"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9133-0"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.828094"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.166"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01053-7"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27068"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02619-1"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-0419-6"}],"container-title":["CPT: Pharmacometrics &amp; Systems Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.70176","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/psp4.70176","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.70176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:19:09Z","timestamp":1778725149000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/psp4.70176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/psp4.70176"],"URL":"https:\/\/doi.org\/10.1002\/psp4.70176","archive":["Portico"],"relation":{},"ISSN":["2163-8306","2163-8306"],"issn-type":[{"value":"2163-8306","type":"print"},{"value":"2163-8306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2025-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70176"}}